Platelet-Rich-Plasma Treating Tennis Elbow
Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: PRP Injection (Biological); Corticosteroid Injection (Biological)
Phase: N/A
Status: Recruiting
Sponsored by: Biomet, Inc. Official(s) and/or principal investigator(s):
Taco Gosens, MD, Principal Investigator, Affiliation: Elisabeth ziekenhuis
Overall contact:
Taco Gosens, MD, Phone: 013-5391313
Summary
The study is to compare the efficacy of autologous platelet concentrate injections to
corticosteroid injection in patients suffering from tennis elbow with respect to pain and
function.
Clinical Details
Official title: Use of Platelet-Rich-Plasma to Treat Tennis Elbow, A Blinded and Randomized Single Center Study
Study design: Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Visual Analog Score - Pain
Secondary outcome: DASHComplications
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patient with chronic epicondylitis lateralis who do not react to conservative
treatment and therefore are send to the orthopedic surgeon
Exclusion Criteria:
Locations and Contacts
Taco Gosens, MD, Phone: 013-5391313
Elisabeth ziekenhuis, Tilburg, Netherlands; Recruiting
Taco Gosens, MD, Phone: 013-5391313
Additional Information
Starting date: August 2007
Ending date: August 2016
Last updated: September 22, 2008
|
